Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Squamous Cell 3Rectal Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Adenocarcinoma Of Esophagus 2Tonsillar Neoplasms 1Resectable Esophageal Cancer 1Pharyngeal Neoplasms 1Neoplasms by Site 1Neoplasms 1Muscle Invasive Bladder Cancer 1Melanoma 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Adenosquamous 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Ipilimumab 98pembrolizumab 84Nivolumab 82aldesleukin 51Cyclophosphamide 49Interleukin-2 38fludarabine phosphate 31Vemurafenib 31Dacarbazine 31dabrafenib 29trametinib 28Temozolomide 26fludarabine 25CTLA-4 Antigen 18Bevacizumab 18Radiosurgery 15Paclitaxel 15Carboplatin 14encorafenib 13binimetinib 13Introns 13talimogene laherparepvec 12Radiotherapy 12Interferon alpha-2 12spartalizumab 11cobimetinib 10atezolizumab 10sargramostim 9peginterferon alfa-2b 9montanide ISA 51 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Melanoma × Chemoradiotherapy × Clear all
NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Massachusetts General Hospital

Phase NA Completed
11 enrolled 8 charts
CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡